Celularity Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Celularity Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Celularity Inc - Ordinary Shares - Class A
Rating: 1.46666675
Author: Trendlyne DVM scores

about

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorde...

1.41 -0.03 (-2.08%)

44.71% Fall from 52W High

96,695

XNAS Volume

XNAS 11 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.7 / 100

Technically Neutral

54.0 / 100

No estimates available

Celularity Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celularity Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorde...

44.71% Fall from 52W High

SWOT Analysis

Celularity Inc (Class A) Live Price Chart

Celularity Inc (Class A) Live Price Chart